ceftriaxone / BrainX Corp 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ceftriaxone / BrainX Corp
NCT03413384: To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia

Recruiting
2
106
RoW
Ceftriaxone, Ceftriaxone Sandoz powder for IV Injection, Placebo
BrainX Corporation, Virginia Contract Research Organization Co., Ltd.
Parkinson's Disease Dementia
12/24
03/25

Download Options